MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617063074 A) filed by Oxford Drug Design Limited on May 19, 2026, for 2-Amino-N-(oxo-Aryl-Lambda6-Sulfanylidene)acetamide Compounds And Their Therapeutic Use.
Inventors include Edmund, Grace; Finn, Paul W.; and Charlton, Michael H..
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to 2-amino-N-(oxo-aryl-A6- sulfanylidene)acetamide compounds (referred to herein as ANOSA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aa...